SANTA CLARA, Calif. & SPOKANE, Wash.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and Signature Genomic Laboratories LLC (Signature) today announced they have signed a long-term supply agreement in which Agilent will supply custom oligonucleotide microarrays to Signature and its customers based on the Signature-designed SignatureChip Oligo Solution (SignatureChipOS). Terms of the agreement were not disclosed.
